INS and type 2 diabetes mellitus: The RISE study demonstrated that the main predictor of worsening glycemia in adolescents with T2D or IGT was baseline β-cell dysfunction, and that neither metformin nor insulin plus metformin prevented deterioration in β-cell function in those with T2D or pre-diabetes, in contrast to adults [38, 44].